| __timestamp | Apellis Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 23138050 |
| Thursday, January 1, 2015 | 13730311 | 57410147 |
| Friday, January 1, 2016 | 22978599 | 41454452 |
| Sunday, January 1, 2017 | 40303878 | 31690298 |
| Monday, January 1, 2018 | 105285576 | 52968505 |
| Tuesday, January 1, 2019 | 220968770 | 81048686 |
| Wednesday, January 1, 2020 | 299921000 | 128874979 |
| Friday, January 1, 2021 | 420869000 | 206342000 |
| Saturday, January 1, 2022 | 387236000 | 297307000 |
| Sunday, January 1, 2023 | 354387000 | 353188000 |
| Monday, January 1, 2024 | 505870000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Apellis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc. have been at the forefront of this race. Since 2014, Apellis has seen a staggering increase in R&D expenses, peaking in 2021 with a 50-fold rise compared to 2014. Meanwhile, Arrowhead has consistently ramped up its R&D investments, culminating in a 2023 expenditure that nearly matches Apellis's peak. Notably, Arrowhead's 2024 data is missing, leaving room for speculation on its future trajectory. This financial commitment underscores the fierce competition and dedication to groundbreaking therapies, with both companies striving to lead in the pharmaceutical innovation landscape.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Apellis Pharmaceuticals, Inc.
GSK plc or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Apellis Pharmaceuticals, Inc.
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc.
Apellis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Arrowhead Pharmaceuticals, Inc. vs ImmunityBio, Inc.
R&D Spending Showdown: Arrowhead Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Research and Development Investment: Arrowhead Pharmaceuticals, Inc. vs Mesoblast Limited